Galera Therapeutics (GRTX) Stock Chart & Stock Price History → Digitizing the $11T commodities sector with one tiny stock (From Resource Stock Digest) (Ad) Free GRTX Stock Alerts $0.20 +0.01 (+5.15%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Galera Therapeutics Stock Price Performance5 Day Performance+10.67%1 Month Performance+5.86%3 Month Performance-25.83%6 Month Performance+35.86%Year-To-Date Performance+35.49%1 Year Performance-93.52% Receive GRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… GRTX Stock Chart for Tuesday, May, 28, 2024 GRTX Chart by TradingView Galera Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/27/2024$0.20$0.20$0.20$0.18782,700 shs$10.66 million05/24/2024$0.18$0.20+10.11%$0.20$0.18760,691 shs$10.66 million05/23/2024$0.19$0.18-4.09%$0.19$0.18288,523 shs$9.68 million05/22/2024$0.19$0.19-2.32%$0.20$0.18138,808 shs$10.10 million05/21/2024$0.19$0.19+1.99%$0.19$0.18267,417 shs$10.33 million05/20/2024$0.20$0.19-4.95%$0.20$0.18327,453 shs$10.13 million Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/17/2024$0.20$0.20+0.36%$0.23$0.19981,241 shs$10.66 million05/16/2024$0.19$0.20+2.79%$0.20$0.19773,658 shs$10.62 million05/15/2024$0.18$0.19+8.51%$0.19$0.18411,294 shs$10.33 million05/14/2024$0.18$0.18-0.51%$0.18$0.17669,566 shs$9.52 million05/13/2024$0.18$0.18-0.06%$0.18$0.17470,971 shs$9.57 million05/10/2024$0.18$0.18-0.56%$0.18$0.161.03 million shs$9.58 million05/09/2024$0.18$0.18-0.51%$0.18$0.17324,152 shs$9.63 million05/08/2024$0.18$0.18+1.19%$0.18$0.17176,703 shs$9.68 million05/07/2024$0.17$0.18+1.68%$0.18$0.17307,544 shs$9.57 million05/06/2024$0.19$0.17-6.99%$0.19$0.17342,869 shs$9.41 million05/03/2024$0.19$0.19-3.93%$0.20$0.182.74 million shs$10.12 million05/02/2024$0.19$0.19+2.00%$0.20$0.191.70 million shs$10.53 million05/01/2024$0.19$0.19+1.88%$0.19$0.18726,364 shs$10.32 million04/30/2024$0.18$0.19+2.03%$0.20$0.17391,480 shs$10.13 million04/29/2024$0.19$0.18-1.88%$0.20$0.18351,464 shs$9.93 million04/26/2024$0.21$0.19-10.31%$0.22$0.192.16 million shs$10.12 million04/25/2024$0.18$0.21+13.57%$0.21$0.18662,154 shs$11.29 million04/24/2024$0.19$0.18-5.82%$0.20$0.16814,562 shs$9.94 million04/23/2024$0.19$0.19+1.68%$0.20$0.19352,721 shs$10.55 million04/22/2024$0.18$0.19+3.70%$0.20$0.18671,577 shs$10.38 million04/19/2024$0.19$0.18-1.08%$0.19$0.18801,588 shs$10.01 million04/18/2024$0.20$0.19-6.25%$0.21$0.173.85 million shs$10.12 million04/17/2024$0.17$0.20+16.71%$0.24$0.1818.20 million shs$10.79 million04/16/2024$0.15$0.17+11.18%$0.17$0.152.55 million shs$9.25 million04/15/2024$0.16$0.15-3.78%$0.16$0.15563,079 shs$8.32 million04/12/2024$0.16$0.16-0.75%$0.16$0.16360,253 shs$8.64 million04/11/2024$0.16$0.16$0.17$0.16239,728 shs$8.71 million04/10/2024$0.16$0.16-1.48%$0.17$0.16374,437 shs$8.71 million04/09/2024$0.16$0.16+0.87%$0.17$0.16296,973 shs$8.84 million04/08/2024$0.17$0.16-2.95%$0.17$0.16601,440 shs$8.76 million04/05/2024$0.16$0.17+2.47%$0.17$0.16424,847 shs$9.03 million04/04/2024$0.15$0.16+5.06%$0.16$0.15759,495 shs$8.81 million04/03/2024$0.15$0.15+2.12%$0.16$0.15882,802 shs$8.39 million04/02/2024$0.17$0.15-9.15%$0.17$0.152.31 million shs$8.21 millionTim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade04/01/2024$0.14$0.17+18.71%$0.21$0.1521.28 million shs$9.04 million03/29/2024$0.14$0.14$0.19$0.134.31 million shs$7.62 million03/28/2024$0.15$0.14-8.79%$0.19$0.133.96 million shs$7.62 million03/27/2024$0.18$0.15-16.58%$0.18$0.152.37 million shs$8.35 million03/26/2024$0.22$0.18-17.86%$0.23$0.183.61 million shs$10.01 million03/25/2024$0.23$0.22-4.27%$0.24$0.211.26 million shs$12.18 million03/22/2024$0.24$0.23-2.70%$0.25$0.23383,207 shs$12.73 million03/21/2024$0.24$0.24-0.82%$0.25$0.24225,586 shs$13.08 million03/20/2024$0.24$0.24+0.41%$0.26$0.24353,330 shs$13.19 million03/19/2024$0.24$0.24-0.33%$0.25$0.24419,916 shs$13.14 million03/18/2024$0.21$0.24+14.73%$0.25$0.231.16 million shs$13.18 million03/15/2024$0.21$0.21+0.09%$0.22$0.21325,885 shs$11.49 million03/14/2024$0.22$0.21-1.86%$0.23$0.21379,054 shs$11.48 million03/13/2024$0.22$0.22-0.78%$0.22$0.21231,634 shs$11.69 million03/12/2024$0.22$0.22-1.54%$0.23$0.21263,205 shs$11.79 million03/11/2024$0.24$0.22-7.79%$0.24$0.22289,649 shs$11.97 million03/08/2024$0.24$0.24-1.24%$0.25$0.23396,033 shs$12.98 million03/07/2024$0.24$0.24+0.96%$0.25$0.23411,780 shs$13.15 million03/06/2024$0.25$0.24-2.29%$0.25$0.23576,039 shs$13.02 million03/05/2024$0.22$0.25+12.59%$0.25$0.211.24 million shs$13.33 million03/04/2024$0.23$0.22-6.89%$0.23$0.191.40 million shs$11.84 million03/01/2024$0.24$0.23-3.83%$0.24$0.22806,955 shs$12.71 million02/29/2024$0.27$0.24-8.51%$0.26$0.241.28 million shs$13.22 million02/28/2024$0.25$0.27+6.20%$0.29$0.224.43 million shs$14.45 million02/27/2024$0.19$0.25+30.26%$0.26$0.2025.83 million shs$13.60 million Related Companies: AEZS Stock Chart VAXX Stock Chart KTRA Stock Chart MNPR Stock Chart ERNA Stock Chart MTEM Stock Chart NCNA Stock Chart ABVC Stock Chart UPC Stock Chart ADXN Stock Chart Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRTX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.